Chimeric antigen receptor (CAR) T cell therapy is offering new hope to cancer patients around the world. As commercial CAR T therapies reach more patients, and new CAR T therapies are developed and approved, optimization of the manufacturing process is critical. Here, we discuss recently published research from Metzloff and colleagues at the University of […]